Clinical Determinants of Myocardial Injury, Detectable and Serial Troponin Levels among Patients with Hypertensive

Giancarlo Acosta1, Ahmed Amro1, Rodrigo Aguilar2

  • 1Cardiology, Marshall University, Huntington, USA.

Cureus
|March 7, 2020
PubMed

Insights

Hypertensive crisis often presents with detectable troponin, but myocardial injury is less common. Low body mass index (BMI) is paradoxically linked to higher troponin levels in these patients.

Area of Science:

  • Cardiology
  • Emergency Medicine
  • Clinical Biochemistry

Background:

  • Hypertensive crisis frequently co-occurs with myocardial injury, indicated by elevated cardiac troponin.
  • Risk factors for troponin elevation and myocardial injury in hypertensive crisis are not well-defined.

Purpose of the Study:

  • To identify predictors of myocardial injury (troponin elevation >99th percentile URL), detectable troponin (>0.015 ng/ml), and increased serial troponin levels in patients with hypertensive crisis.

Main Methods:

  • Retrospective study of 467 patients diagnosed with hypertensive crisis (ICD-10-CM codes) between 2016-2018.
  • Logistic regression analysis was employed to determine significant risk factors.

Main Results:

  • 15% of patients experienced myocardial injury; risk factors included congestive heart failure (CHF) and prior aspirin use, while lower BMI (<30 kg/m2) was protective.
  • 35% had detectable troponin; associated factors were CHF, elevated creatinine, and younger age (<61 years), with lower BMI being protective.
  • Factors for increased serial troponin included CHF, coronary artery disease (CAD), and non-Caucasian race; lower BMI was again protective.

Conclusions:

  • A significant proportion of hypertensive crisis patients have detectable troponin, but fewer meet criteria for myocardial injury.
  • Lower BMI is paradoxically associated with higher troponin levels, an 'obesity paradox,' particularly in females and older individuals.
  • Congestive heart failure and coronary artery disease are key indicators for troponin elevation in hypertensive crisis.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
704
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
152
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
379
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
468
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
604
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
295